Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SiderAL Med
- Development stage
- Unknown
- Lead developer
- Pharmanutra
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
SiderAL Med is a food for special medical purposes formulated to address nutritional deficiencies, particularly in bariatric patients and individuals with malabsorption syndromes. It contains a comprehensive blend of vitamins (A, C, D, E, K, PP/niacinamide, B5/pantothenic acid, B6/pyridoxine hydrochloride, B9/folate, B12/cyanocobalamin) and minerals (including iron as Sucrosomial Iron/ferric pyrophosphate r.m., seaweed calcium/Aquamin from Lithothamnium calcareum, magnesium oxide/Ultramag®, zinc oxide/Ultrazin®, sodium selenite/Ultrasel®, copper citrate), all protected by patented Sucrosomial Technology to enhance absorption and tolerability. The formulation is gluten-free and lactose-free. Its primary mechanism is the correction of micronutrient deficiencies through improved bioavailability of iron and other minerals without interfering with the absorption of other nutrients. The product is designed for use under medical supervision and not intended as the sole source of nutrition[2].
- Brand names
- SiderAL Med
Beyond the preview
Go deeper on SiderAL Med.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SiderAL Med.